publications High-Cost Therapy Profile: July 2025 Rebisufligene etisparvovec Intravenous (IV) Metabolic gene therapy July 3, 2025 Proposed indications Sanfilippo A syndrome (Mucopolysaccharidosis...

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

publications Summer 2025 Issue: Spotlight on HIV and Specialty Drug Trends New therapies, payer strategies and pipeline updates shaping the future of managed care July 15, 2025 The Prime...

Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

Journal of Managed Care & Specialty Pharmacy (JMCP)

Read Clinical News: June 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics MDMA-ASSISTED THERAPY FOR PTSD...